Lubabegron

DB20289ExperimentalSmall molecule

Lubabegron is a small molecule drug. The usage of the INN stem '-begron' in the name indicates that Lubabegron is a β3 adrenoreceptor agonists. Lubabegron has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Beta-3 adrenergic receptor and Beta adrenergic receptor
Curator reviewed
Formula / weight: C₂₉H₂₉N₃O₃S · 499.63 g/mol (avg)
Code names: LY-488756

Resolves to

Compound

UNII8501207BZXCAS391920-32-4ChEMBLCHEMBL2364615ChEBI754976PubChem60085980

Clinical / RWD

RxNorm2360331

Structure

InChIKeyWIKLBKJBYSBYLL-QHCPKHFHSA-NSMILESCC(C)(CC1=CC=C(OC2=C(C=CC=N2)C#N)C=C1)NC[C@H](O)COC1=C(C=CC=C1)C1=CC=CS1

Targets

P13945ADRB3P08588ADRB1P07550ADRB2

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lubabegron, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account